MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Corticobasal degeneration (CBD)"

  • 2023 International Congress

    Determinants of care partner burden in atypical parkinsonian syndromes

    M. Ivancic, J. Shurer, M. Schmidt, V. Nesspor, M. Li, Y. Lin, R. Xu, G. Schumock, M. Sklerov, A. Pantelyat (Chapel Hill, USA)

    Objective: To understand the determinants of burden among people caring for individuals diagnosed with progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), or multiple system atrophy…
  • 2023 International Congress

    Early-onset cortico-basal degeneration (CBD) due to a c.2092G>A MAPT mutation

    M. Mata Alvarez-Santullano, L. Lopez-Manzanares, J. Lopez-Lozano, N. Villares, C. Magdaleno, C. Dela Torre (Madrid, Spain)

    Objective: To describe a patient with early-onset atypical parkinsonism that evolved to a classic CBD without dementia, associated to a c.2092G>A MAPT mutation Background: Although…
  • 2023 International Congress

    Autoimmune encephalitis due to antiglycine antibodies presenting as corticobasal syndrome

    S. Secades (Madrid, Spain)

    Objective: To describe a complex case of atypical parkinsonism compatible with corticobasal syndrome (CBS), associated with autoimmune findings in serum and cerebrospinal fluid (CSF) and…
  • 2023 International Congress

    Creutzfeldt-Jakob Disease misdiagnosed as Corticobasal degeneration

    M. Elkasaby, C. Duffy, B. Appleby (Cleveland, USA)

    Objective: We described clinical, radiologic, and neuropathological findings of a patient with Creutzfeldt-Jakob Disease who presented antemortem with clinical features suggestive of corticobasal degeneration. Background:…
  • 2023 International Congress

    The Pistol Sign

    S H. Wimalaratna (Oxford, United Kingdom)

    Objective: To describe a specific dystonic feature associated with corticobasal degeneration(CBD). Background: Dystonia is common in atypical parkinsonian disorders such as multiple system atrophy, progressive…
  • 2023 International Congress

    Atypical parkinsonism syndromes: clinical presentations

    A. Gunduz, S. Akkus, FZ. Calikusu, E. Koçhan Kızılkılıç, B. Poyraz, A. Altunç, G. Kızıltan (Istanbul, Turkey)

    Objective: Here, our aim was to identify the characteristics of atypical clinical presentations of atypical parkinsonism syndromes in our cohort and our secondary aim was…
  • 2023 International Congress

    18F-Florzolotau PET imaging of tau pathology in the living brain of patients with corticobasal syndrome

    FT. Liu, JY. Lu, XY. Li, YM. Sun, JJ. Wu, TC. Yen, QH. Zhao, CT. Zuo, J. Wang (Shanghai, China)

    Objective: To analyze the topographical patterns of tau pathology in the living brains of patients with CBS using 18F-Florzolotau PET imaging and to examine whether…
  • 2023 International Congress

    Identification of a Metabolic Brain Pattern Specific to Corticobasal Degeneration and Its Utility in Differential Diagnosis

    T. Rus, J. Jamšek, M. Perovnik, M. Trošt (Ljubljana, Slovenia)

    Objective: To identify a metabolic brain pattern specific to corticobasal degeneration (CBD) and to develop a machine learning algorithm that can differentiate CBD from other…
  • 2023 International Congress

    Atypical Parkinsonian Syndrome with evocative brain MRI imaging. About seven cases.

    CH. Boukadir, F. Ferrat, S. Ouardi, S. Bouchaour, M. Boukhalfa, L. Kasmi, M. Akareb, S. Bahlali, W. Amer Elkhedoud (Ben Aknoun, Algiers, Algeria)

    Objective: The diagnosis of Parkinson's disease and parkinsonian syndromes remains clinically difficult, is based on clinical diagnostic criteria, MRI plays a major role in the…
  • 2023 International Congress

    Neurofilament light chain, tau-PET and microglia-PET predict clinical progression in amyloid-negative corticobasal syndrome

    C. Palleis, N. Franzmeier, E. Weidinger, S. Katzdobler, N. Albert, O. Sabri, H. Barthel, R. Rupprecht, BS. Rauchmann, R. Perneczky, C. Haass, J. Levin, M. Brendel, GU. Hoeglinger (Munich, Germany)

    Objective: A head-to-head comparison of neuroimaging (tau-PET, microglia-PET, structural MRI) and plasma biomarker Neurofilament light chain (NfL) as prognostic tools for longitudinal clinical trajectories in…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 10
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • To be or not to bupropion: a drug-induced parkinsonism?
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #25676 (not found)
  • Crack Dancing: An Uncommon Drug-Induced Chorea
  • #24376 (not found)
  • #24970 (not found)
  • Welcome to the MDS Abstracts Site
  • Effect of marijuana on Essential Tremor: A case report
  • Advanced Search
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley